Working Through the Public Disclosure Process Mandated by Use of 21 CFR 50.24 (Exception to Informed Consent): Guidelines for Success
Santora, Thomas A.
Trooskin, Stanley Z.
Journal of Trauma: Injury, Infection, and Critical Care 1998 November; 45(5): 907-913
Showing items related by title, author, creator and subject.
Recommendations for Implementation of Community Consultation and Public Disclosure Under the Food and Drug Administration's "Exception From Informed Consent Requirements for Emergency Research": A Special Report From the American Heart Association Emergency Cardiovascular Care Committee and Council on Cardiopulmonary, Perioperative and Critical Care: Endorsed by the American College of Emergency Physicians and the Society for Academic Emergency Medicine Halperin, Henry; Paradis, Norman; Mosesso, Vincent Jr.; Nichol, Graham; Sayre, Michael; Ornato, Joseph P.; Gerardi, Michael; Nadkarni, Vinay M.; Berg, Robert; Becker, Lance; Siegler, Mark; Collins, Megan; Cairns, Charles B.; Biros, Michelle H.; Vanden Hoek, Terry; Peberdy, Mary Ann (2007-10-16)
Public Disclosure in Research With Exception From Informed Consent: The Use of Survey Methods to Assess Its Effectiveness Jacoby, Liva H.; Young, Barry; Watt, James (2008-03)IN CLINICAL TRIALS WITH EXCEPTION from informed consent, the Final Rule stipulates that investigators inform and consult with the community. A random-digit-dialing survey of 200 individuals assessed the effectiveness of ...